160 related articles for article (PubMed ID: 38230565)
1. SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10.
Wu K; Gong W; Sun H; Li W; Chen L; Duan Y; Zhu J; Zhang H; Ke H
Cancer Rep (Hoboken); 2024 Jan; 7(2):e1976. PubMed ID: 38230565
[TBL] [Abstract][Full Text] [Related]
2. ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway.
Liu L; Xie D; Xie H; Huang W; Zhang J; Jin W; Jiang W; Xie D
Onco Targets Ther; 2019; 12():11507-11516. PubMed ID: 31920339
[TBL] [Abstract][Full Text] [Related]
3. ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway.
Lin LL; Yang F; Zhang DH; Hu C; Yang S; Chen XQ
Cancer Cell Int; 2021 Jun; 21(1):320. PubMed ID: 34174897
[TBL] [Abstract][Full Text] [Related]
4. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
Ma N; Zhao Y
Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
[TBL] [Abstract][Full Text] [Related]
5. HK2 is associated with the Warburg effect and proliferation in liver cancer: Targets for effective therapy with glycyrrhizin.
Sun Z; Tan Z; Peng C; Yi W
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760124
[TBL] [Abstract][Full Text] [Related]
6. ARHGAP10, Transcriptionally Regulated by Sodium Butyrate, Promotes Ferroptosis of Ovarian Cancer Cells.
Ke H; Shao J; Hu J; Song X; Han H; Zhu Z; Zhou X; Chen L; Shan Y
Front Biosci (Landmark Ed); 2024 Apr; 29(5):167. PubMed ID: 38812318
[TBL] [Abstract][Full Text] [Related]
7. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
8. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
Li Z; Jin Q; Sun Y
J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10 accelerates glycolysis through binding HK2 to promote the malignant progression of oral squamous cell carcinoma.
Cai Y; Li H; Xie D; Zhu Y
Discov Oncol; 2024 Apr; 15(1):132. PubMed ID: 38671310
[TBL] [Abstract][Full Text] [Related]
10. The roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells.
Teng JP; Yang ZY; Zhu YM; Ni D; Zhu ZJ; Li XQ
Oncol Lett; 2017 Oct; 14(4):4613-4618. PubMed ID: 28943961
[TBL] [Abstract][Full Text] [Related]
11. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
12. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer.
Zheng YZ; Liang L
Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721
[TBL] [Abstract][Full Text] [Related]
13. TKTL1 participated in malignant progression of cervical cancer cells via regulating AKT signal mediated PFKFB3 and thus regulating glycolysis.
Zhu Y; Qiu Y; Zhang X
Cancer Cell Int; 2021 Dec; 21(1):678. PubMed ID: 34922556
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
15. REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
Jiang L; Liu Y; Liu M; Zheng Y; Chen L; Shan F; Ji J; Cao Y; Kai H; Kang X
Environ Toxicol; 2024 Jan; 39(1):85-96. PubMed ID: 37665173
[TBL] [Abstract][Full Text] [Related]
16. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
17. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway.
Wang K; Li J; Zhou B
Metab Brain Dis; 2022 Feb; 37(2):489-499. PubMed ID: 34792707
[TBL] [Abstract][Full Text] [Related]
18. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/
Shi Q; Ji T; Ma Z; Tan Q; Liang J
Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058
[No Abstract] [Full Text] [Related]
19. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma.
Dai H; Yi G; Jiang D; Min Y; Li Z
J Orthop Surg Res; 2024 Jan; 19(1):67. PubMed ID: 38218855
[TBL] [Abstract][Full Text] [Related]
20. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
Qiao L; Dong C; Ma B
J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
